Skip to main content
. 2019 Sep 25;18(5):3853–3860. doi: 10.3892/etm.2019.8046

Figure 3.

Figure 3.

ZFAND5 is a candidate target of miR-96-5p. (A) Expression of selected miR-96-5p target genes. (B) The aberrant expression of the target genes was validated using The Cancer Genome Atlas dataset. Kaplan-Meier analysis of overall survival for patients with hepatocellular carcinoma with high vs. low expression of (C) ZFAND5 and (D) NTN4. ZFAND5, zinc finger AN1-type containing 5; miRNA, microRNA; T, tumor samples; NT, non-tumor tissue samples; HR, hazard ratio; NTN4, netrin 4; LPP, LIM domain containing preferred translocation partner in lipoma.